In certain groups of men, glucose-6-phosphate dehydrogenase (G6PD) deficiency was linked with an increased likelihood of severe COVID-19, a Veterans Affairs cohort study found. In Black men under 65, ...

DURHAM, N.C. – Many people who undergo treatment for hepatitis C develop hemolytic anemia, a disorder that destroys red blood cells. In some cases, it is so severe they have to reduce their medication ...

The first-ever treatment for an extremely rare and often fatal genetic disease that interferes with the body’s ability to tap built-up stores of sugar for energy received federal approval Friday. The ...

Editor’s note: Each week WRAL TechWire takes a deep dive into a particular company or technology or personality. Today it’s medtech. RESEARCH TRIANGLE PARK – Baebies, a medical device and diagnostics ...

An ultra-rare enzyme deficiency that keeps infants from achieving proper muscle function among other developmental delays now has its first FDA-approved treatment. The new product, a gene therapy ...

This is a preview. Log in through your library . Abstract 67/369 male Saudi subjects (18%) were found to be G6PD deficient on screening, and electrophoresis of blood samples stored on filter paper ...

Medically reviewed by Allison Herries, RDNMedically reviewed by Allison Herries, RDN Lactase is a digestive enzyme involved in the breakdown of lactose, a sugar found in milk and other dairy products.

In AATD, patients lack a critical liver enzyme that helps prevent vital proteins from being degraded due to mutations in the ...

Please provide your email address to receive an email when new articles are posted on . Click here to read the Cover Story, “After decades with only one option, new therapies emerge for congenial ...